Value of PAPP-A combined with BMI in predicting the prognosis of gestational diabetes mellitus: an observational study

References

• Barnea ER, Bischoff P, Page C, DeCherney AH, Herrmann W, Naftolin F. 1986. Placental and circulating pregnancy-associated plasma protein A concentrates in normal and pathological term pregnancies. Obstetrics and Gynecology 68:382–386.
   PubMed Web of Science ®Google Scholar
• Bonaca MP, Scirica BM, Sabatine MS, Jarolim P, Murphy SA, Chamberlin JS, et al. 2012. Prospective evaluation of pregnancy-associated plasma protein-A and outcomes in patients with acute coronary syndromes. Journal of the American College of Cardiology 60:332–338.
   PubMed Web of Science ®Google Scholar
• Britton LE, Hussey JM, Berry DC, Crandell JL, Brooks JL, Bryant AG. 2019. Contraceptive use among women with prediabetes and diabetes in a US national sample. Journal of Midwifery & Women's Health 64:36–45.
   PubMed Web of Science ®Google Scholar
• Byun D, Mohan S, Yoo M, Sexton C, Baylink DJ, Qin X. 2001. Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro. Journal of Clinical Endocrinology & Metabolism 86:847–854.
   PubMed Web of Science ®Google Scholar
• Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM, et al. 2008. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 29:274–281.
   PubMed Web of Science ®Google Scholar
• Correa A, Bardenheier B, Elixhauser A, Geiss LS, Gregg E. 2015. Trends in prevalence of diabetes among delivery hospitalizations, United States, 1993-2009. Maternal and Child Health Journal 19:635–642.
   PubMed Web of Science ®Google Scholar
• Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, et al. 2000. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 49:2208–2211.
   PubMed Web of Science ®Google Scholar
• Ding TT, Xiang J, Luo BR, Hu J. 2018. Relationship between the IADPSG-criteria-defined abnormal glucose values and adverse pregnancy outcomes among women having gestational diabetes mellitus: a retrospective cohort study. Medicine 97:e12920.
   PubMed Web of Science ®Google Scholar
• Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, et al. 2004. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). American Journal of Obstetrics and Gynecology 191:1446–1451.
   PubMed Web of Science ®Google Scholar
• Eades CE, Cameron DM, Evans JMM. 2017. Prevalence of gestational diabetes mellitus in Europe: a meta-analysis. Diabetes Research and Clinical Practice 129:173–181.
   PubMed Web of Science ®Google Scholar
• Feig DS, Hwee J, Shah BR, Booth GL, Bierman AS, Lipscombe LL. 2014. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996-2010. Diabetes Care 37:1590–1596.
   PubMed Web of Science ®Google Scholar
• Griffin JF. 1983. Pregnancy-associated plasma protein levels at term in normal pregnancy, preeclampsia and essential hypertension. The Australian & New Zealand Journal of Obstetrics & Gynaecology 23:11–14.
   PubMed Web of Science ®Google Scholar
• Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Group HSCR, et al. 2008. Hyperglycemia and adverse pregnancy outcomes. New England Journal of Medcine 358:1991–2002.
   PubMed Web of Science ®Google Scholar
• Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Renzo GCD, et al. 2015. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 131 Suppl 3: S173–S211.
   PubMed Web of Science ®Google Scholar
• Holmes VA, Young IS, Patterson CC, Pearson DWM, Walker JD, Maresh MJA, for the Diabetes and Pre-eclampsia Intervention Trial Study Group, et al. 2011. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care 34:1683–1688.
   PubMed Web of Science ®Google Scholar
• Hu J, Gao J, Liu J, Meng H, Hao N, Song Y, et al. 2021. Prospective evaluation of the first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China. Ultrasound in Obstetrics and Gynecology 58:529–539.
   PubMed Web of Science ®Google Scholar
• Karahasanovic A, Sorensen S, Nilas L. 2014. First trimester pregnancy-associated plasma protein A and human chorionic gonadotropin-beta in early and late pre-eclampsia. Clinical Chemistry and Laboratory Medicine 52:521–525.
   PubMed Web of Science ®Google Scholar
• Kim WJ, Chung Y, Park J, Park JY, Han K, Park Y, et al. 2021. Influences of pregravid liver enzyme levels on the development of gestational diabetes mellitus. Liver International 41:743–753.
   PubMed Web of Science ®Google Scholar
• Koivusalo SB, Rono K, Klemetti MM, Roine RP, Lindstrom J, Erkkola M, et al. 2016. Gestational diabetes mellitus can be prevented by lifestyle intervention: the Finnish Gestational Diabetes Prevention Study (RADIEL). A randomized controlled trial. Diabetes Care 39:24–30.
   PubMed Web of Science ®Google Scholar
• Li Y, Teng D, Shi X, Shi XG, Qin GJ, Qin YF, et al. 2020. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ (Clinical Research ed.) 369:m997.
   PubMedGoogle Scholar
• Lu L, Koulman A, Petry CJ, Jenkins B, Matthews L, Hughes LA, et al. 2016. An unbiased lipidomics approach identifies early second trimester lipids predictive of maternal glycemic traits and gestational diabetes mellitus. Diabetes Care 39:2232–2239.
   PubMed Web of Science ®Google Scholar
• Morris JR, Tepper NK. 2019. Description and comparison of postpartum use of effective contraception among women with and without diabetes. Contraception 100:474–479.
   PubMed Web of Science ®Google Scholar
• Overgaard MT, Haaning J, Boldt HB, Olsen IM, Laursen LS, Christiansen M, et al. 2000. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. Journal of Biological Chemistry 275:31128–31133.
   PubMed Web of Science ®Google Scholar
• Patil M, Panchanadikar TM, Wagh G. 2014. Variation of papp-a level in the first trimester of pregnancy and its clinical outcome. Journal of Obstetrics and Gynaecology of India 64:116–119.
   PubMedGoogle Scholar
• Perović M, Garalejić E, Gojnić M, Arsić B, Pantić I, Bojović DJ, et al. 2012. Sensitivity and specificity of ultrasonography as a screening tool for gestational diabetes mellitus. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies. The International Society of Perinatal Obstetricians 25:1348–1353.
   Google Scholar
• Perovic M, Gojnic M, Arsic B, Pantic I, Stefanovic T, Kovacevic G, et al. 2015. Relationship between mid-trimester ultrasound fetal liver length measurements and gestational diabetes mellitus. Journal of Diabetes 7:497–505.
   PubMed Web of Science ®Google Scholar
• Petry CJ, Ong KK, Hughes IA, Acerini CL, Frystyk J, Dunger DB. 2017. Early pregnancy-associated plasma protein a concentrations are associated with third trimester insulin sensitivity. The Journal of Clinical Endocrinology and Metabolism 102:2000–2008.
   PubMed Web of Science ®Google Scholar
• Pillai RN, Konje JC, Tincello DG, Potdar N. 2016. Role of serum biomarkers in the prediction of outcome in women with threatened miscarriage: a systematic review and diagnostic accuracy meta-analysis. Human Reproduction Update 22:228–239.
   PubMed Web of Science ®Google Scholar
• Poblete JA, Olmos P. 2021. Obesity and gestational diabetes in pregnant care and clinical practice. Current Vascular Pharmacology 19:154–164.
   PubMed Web of Science ®Google Scholar
• Rojas-Rodriguez R, Ziegler R, DeSouza T, Majid S, Madore AS, Amir N, et al. 2020. PAPPA-mediated adipose tissue remodeling mitigates insulin resistance and protects against gestational diabetes in mice and humans. Science Translational Medicine 12: eaay4145.
   PubMed Web of Science ®Google Scholar
• Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, IDF Diabetes Atlas Committee, et al. 2019. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(. Diabetes Research and Clinical Practice 157:107843.
   PubMed Web of Science ®Google Scholar
• Seshiah V, Cynthia A, Balaji V, Balaji MS, Ashalata S, Sheela R, et al. 2008. Detection and care of women with gestational diabetes mellitus from early weeks of pregnancy results in birth weight of newborn babies appropriate for gestational age. Diabetes Research and Clinical Practice 80:199–202.
   PubMed Web of Science ®Google Scholar
• Sifakis S, Androutsopoulos VP, Pontikaki A, Velegrakis A, Papaioannou GI, Pontikaki A, et al. 2018. Placental expression of PAPPA, PAPPA-2 and PLAC-1 in pregnacies is associated with FGR. Molecular Medicine Reports 17:6435–6440.
   PubMed Web of Science ®Google Scholar
• Sirimarco MP, Guerra HM, Lisboa EG, Vernini JM, Cassetari BN, de Araujo Costa RA, et al. 2017. Diagnostic protocol for gestational diabetes mellitus (GDM) (IADPSG/ADA, 2011): influence on the occurrence of GDM and mild gestational hyperglycemia (MGH) and on the perinatal outcomes. Diabetology & Metabolic Syndrome 9:2.
   PubMed Web of Science ®Google Scholar
• Syngelaki A, Kotecha R, Pastides A, Wright A, Nicolaides KH. 2015. First-trimester biochemical markers of placentation in screening for gestational diabetes mellitus. Metabolism: clinical and Experimental 64:1485–1489.
   PubMed Web of Science ®Google Scholar
• Tenenbaum-Gavish K, Sharabi-Nov A, Binyamin D, Moller HJ, Danon D, Rothman L, et al. 2020. First trimester biomarkers for prediction of gestational diabetes mellitus. Placenta 101:80–89.
   PubMed Web of Science ®Google Scholar
• Ueland T, Michelsen AE, Aukrust P, Henriksen T, Bollerslev J, Lekva T. 2018. Adipokines and macrophage markers during pregnancy – possible role for sCD163 in prediction and progression of gestational diabetes mellitus. Diabetes/Metabolism Research and Reviews 35:e3114.
   Web of Science ®Google Scholar
• van der Heijden RA, Rijndertse MM, Bierma-Zeinstra SMA, van Middelkoop M. 2018. Lower pressure pain thresholds in patellofemoral pain patients, especially in female patients: a cross-sectional case-control study. Pain Medicine (Malden, Mass.) 19:184–192.
   PubMed Web of Science ®Google Scholar
• Vedel C, Rode L, Bundgaard H, Iversenet K, Jorgensen FS, Petersen OB, et al. 2021. Prenatal cardiac biometries and flow assessments in fetuses at 20 weeks with a bicuspid aortic valve compared to healthy controls: a multicenter, cohort study. Ultrasound in Obstetrics and Gynecology undefined.
   Google Scholar
• Wang P, Ma H-H, Hou X-Z, Song L-L, Song X-L, Zhang J-F, et al. 2018. Reduced plasma level of irisin in first trimester as a risk factor for the development of gestational diabetes mellitus. Diabetes Research and Clinical Practice 142:130–138.
   PubMed Web of Science ®Google Scholar
• Yang J, Ling Y, Yuan J, Pang WY, He C. 2011. Isolation and characterization of peacock Chlamydophila psittaci infection in China. Avian Diseases 55:76–81.
   PubMed Web of Science ®Google Scholar